ECUR-506
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ECUR-506, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency [Phase 1, Phase 2]